Main menu

NEW YORK (GenomeWeb) – BioGx announced it has received CE-IVD marking for a real-time PCR-based test to detect Influenza A, Influenza B, and respiratory syncytial virus.

The assay uses samples from nasopharyngeal swabs and runs on the Becton Dickinson BD Max system. Offered as a single tube that snaps into the BD Max RNA/DNA extraction cartridge, the test increases lab efficiency, the firm said in a statement.

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.